Skip to content
Nonprofiteer
← LAZAREX CANCER FOUNDATION

Form 990 for tax year 2023

Filed by LAZAREX CANCER FOUNDATION.

Totals

Total revenue
$3,734,815
Total expenses
$6,230,037
Contributions and grants received
$3,542,554
Grants paid
$4,416,846
Program service revenue
$0
Investment income
$148,475
Other revenue
$43,786
Total assets, end of year
$4,149,538
Total liabilities, end of year
$1,573,884
Net assets or fund balances, end of year
$2,575,654
Program services expenses (Part IX)
$5,589,345
Management and general expenses
$308,792
Fundraising expenses
$331,900
Program service expenses (Part III)
$5,589,345

Program services were 89.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $407,561

  • 1f · All other contributions, gifts and grants

    $3,134,993

  • 3 · Investment income

    total $149,292 · excluded $149,292

  • 4 · Income from investment of tax-exempt bond proceeds

    total $0

  • 5 · Royalties

    total $0

  • 6d · Net rental income or loss

    total $0

  • 7a · Gross sales of assets other than inventory

    other assets $1,000

  • 7b · Less cost or other basis and sales expenses

    other assets $1,817

  • 7c · Gain or loss

    other assets -$817

  • 7d · Net gain or loss

    total -$817 · excluded -$817

  • 8a · Fundraising events: gross income

    $127,996

  • 8a · Fundraising events: contributions included on line 1c

    $407,561

  • 8b · Fundraising events: direct expenses

    $151,091

  • 8c · Net income from fundraising events

    total -$23,095 · excluded -$23,095

  • 9c · Net income from gaming

    total $0

  • 10c · Net income from sales of inventory

    total $0

  • 11a · Other revenue: PATH Sponsors

    total $1,547 · related or exempt $1,547

  • 11b · Other revenue: UTSW Admin Services

    total $32,000 · related or exempt $32,000

  • 11c · Other revenue: UTSW Impact

    total $31,801 · related or exempt $31,801

  • 11d · All other revenue

    total $1,533 · related or exempt $1,533

  • 11e · Other revenue, total

    $66,881

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $1,105,979 · program services $1,105,979

  • 2 · Grants to domestic individuals

    total $3,310,867 · program services $3,310,867

  • 3 · Grants to foreign organizations and individuals

    total $0

  • 4 · Benefits paid to or for members

    total $0

  • 5 · Compensation of officers, directors and key employees

    total $232,740 · program services $162,918 · management and general $46,548 · fundraising $23,274

  • 6 · Compensation of disqualified persons

    total $0

  • 7 · Other salaries and wages

    total $869,715 · program services $608,801 · management and general $63,697 · fundraising $197,217

  • 8 · Pension plan contributions

    total $0

  • 9 · Other employee benefits

    total $100,400 · program services $75,421 · management and general $8,271 · fundraising $16,708

  • 10 · Payroll taxes

    total $89,971 · program services $62,980 · management and general $8,907 · fundraising $18,084

  • 11a · Fees: management

    total $0

  • 11b · Fees: legal

    total $473 · management and general $473

  • 11c · Fees: accounting

    total $70,151 · management and general $70,151

  • 11d · Fees: lobbying

    total $0

  • 11e · Fees: professional fundraising services

    total $0

  • 11f · Fees: investment management

    total $0

  • 11g · Fees: other

    total $73,947 · program services $22,872 · management and general $51,075

  • 12 · Advertising and promotion

    total $88,364 · program services $68,292 · fundraising $20,072

  • 13 · Office expenses

    total $10,713 · program services $8,110 · management and general $863 · fundraising $1,740

  • 14 · Information technology

    total $73,336 · program services $59,795 · management and general $4,249 · fundraising $9,292

  • 15 · Royalties

    total $0

  • 16 · Occupancy

    total $105,730 · program services $54,133 · management and general $32,287 · fundraising $19,310

  • 17 · Travel

    total $14,334 · program services $13,267 · management and general $333 · fundraising $734

  • 18 · Travel or entertainment for public officials

    total $0

  • 19 · Conferences, conventions and meetings

    total $0

  • 20 · Interest

    total $0

  • 21 · Payments to affiliates

    total $0

  • 22 · Depreciation, depletion and amortization

    total $0

  • 23 · Insurance

    total $2,350 · management and general $2,350

  • 24a · Other expenses: Dues and Subscriptions

    total $30,852 · management and general $15,426 · fundraising $15,426

  • 24b · Other expenses: Telephone and Internet

    total $15,218 · program services $11,509 · management and general $1,236 · fundraising $2,473

  • 24c · Other expenses: Printing and Publications

    total $15,125 · program services $15,125

  • 24d · Other expenses: Postage and Shipping

    total $6,702 · program services $2,749 · management and general $287 · fundraising $3,666

  • 24e · All other expenses

    total $13,070 · program services $6,527 · management and general $2,639 · fundraising $3,904

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $2,306,875 · end of year $246,062

  • 2 · Savings and temporary cash investments

    beginning of year $3,685,246 · end of year $3,068,940

  • 3 · Pledges and grants receivable

    beginning of year $186,727 · end of year $198,509

  • 4 · Accounts receivable

    beginning of year $9 · end of year $0

  • 5 · Loans and receivables from officers and key people

    end of year $0

  • 6 · Loans and receivables from disqualified persons

    end of year $0

  • 7 · Other notes and loans receivable

    end of year $0

  • 8 · Inventories for sale or use

    end of year $0

  • 9 · Prepaid expenses and deferred charges

    beginning of year $1,211 · end of year $941

  • 10a · Land, buildings and equipment: cost or other basis

    $33,863

  • 10b · Land, buildings and equipment: accumulated depreciation

    $23,387

  • 10c · Land, buildings and equipment, net

    beginning of year $18,904 · end of year $10,476

  • 11 · Investments: publicly traded securities

    end of year $0

  • 12 · Investments: other securities

    end of year $0

  • 13 · Investments: program-related

    end of year $0

  • 14 · Intangible assets

    beginning of year $698,496 · end of year $615,641

  • 15 · Other assets

    beginning of year $4,969 · end of year $8,969

  • 17 · Accounts payable and accrued expenses

    beginning of year $640,325 · end of year $496,059

  • 19 · Deferred revenue

    beginning of year $487,927 · end of year $446,380

  • 25 · Other liabilities

    beginning of year $704,950 · end of year $631,445

  • 27 · Net assets without donor restrictions

    beginning of year $675,577 · end of year $66,954

  • 28 · Net assets with donor restrictions

    beginning of year $4,393,658 · end of year $2,508,700

Mission and programs · 2023

Mission

We strive to improve cancer health outcomes, FDA cancer clinical trial diversity and enrollment, and patient access to care by providing assistance with clinical trial navigation, reimbursing trial related travel costs, and partnering with at-risk communities to mobilize resources.

Activities or mission (Part I)

Financial assistance for cancer patients to defray the costs of FDA approved clinical trials.

  • Lazarex CARE Program: This program focuses on improving the outcome of cancer care for advanced stage cancer patients and the medically underserved by identifying FDA clinical trial options, providing assistance with out-of-pocked travel expenses for clinical trial participation and a travel companion if needed, and by facilitating community outreach and engagement. In 2023, we assisted 1236 patients with this program, an increase of 28% over 2022. We continue to increase racial and ethnic diversity of participants in this program, achieving 37%, while the national average in cancer clinical trials at about 5%. 30% of patients assisted came from households earning less than $25,000 annually.

    Expenses $3,183,026 · Grants $2,835,182

  • Lazarex Cancer Wellness Hub Program: Lazarex Cancer Wellness Hubs operated in Philadelphia through Drexel University and Penn Abramson, in Los Angeles through USC Norris, and in the San Francisco East Bay area in collaboration with Monument Crisis Center. The goal of the Lazarex Cancer Wellness Hub Program is to generate a replicable program that is place based, culturally appropriate, and community driven, that operates in at-risk communities of color across the continuum of cancer care to improve cancer health disparities and improve cancer health outcomes.

    Expenses $1,348,810 · Grants $756,904

  • Lazarex IMPACT Program: The goal of IMPACT is to generate a sustainable proof of concept action plan to transform the status quo of clinical trial recruitment, enrollment, retention, minority participation, completion, and translational science, most importantly providing equitable and timely access to cancer discovery for all patients. In 2023, IMPACT was in operation at Penn Abramson, UTSW, USOR, and MD Anderson Comprehensive Cancer Center. In 2023 we served 602 patients in this program, with 37% minority participation, and 25% from households earning less than $25,000 annually.

    Expenses $1,057,509 · Grants $824,760

As filed on the 2023 return.

Listed in Part VII

  • Stephanie Rivera thru 1123

    CEO

    Total calculated
    $232,740
    From this org
    $215,982
    From related orgs
    $0
    Other
    $16,758
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $215,982
    Bonus
    not reported
    Other
    not reported
    Deferred
    $6,931
    Nontaxable benefits
    $9,827
    Filer's total
    $232,740
  • Clay Jackson

    Chairman

    Total calculated
    $0
    Hours/week
    2
  • Kenny J Simansky

    Vice President

    Total calculated
    $0
    Hours/week
    2
  • Kwame Boateng

    CFO

    Total calculated
    $0
    Hours/week
    2
  • Darlene Chiang

    Secretary

    Total calculated
    $0
    Hours/week
    2
  • Dr Frank Crnkovich

    Director

    Total calculated
    $0
    Hours/week
    2
  • Greg Francisco

    Director

    Total calculated
    $0
    Hours/week
    2
  • Karen Sessions

    Director

    Total calculated
    $0
    Hours/week
    2
  • Ahmad Alrawi

    Director

    Total calculated
    $0
    Hours/week
    2
  • Elaine MacNeilly

    Director

    Total calculated
    $0
    Hours/week
    2
  • Jackie Kent

    Director

    Total calculated
    $0
    Hours/week
    2
  • Fabian Sandoval

    Director

    Total calculated
    $0
    Hours/week
    2
  • Dana Dornsife

    CEO

    Total calculated
    $0
    Hours/week
    40

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment

Answered no

  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

Part III, Additional Information
The board approves compensation of management.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

  • USC Norris Cancer Center

    $376,690

  • Drexel University

    $245,278

  • Penn Abramson

    $175,610

  • Univ of Texas MD Anderson

    $87,065

  • US Oncology Research LLC

    $86,400

  • Center for Human Development

    $34,869

  • Monument Impact

    $34,869

  • Village Community Center

    $34,869

  • Monument Crisis Center

    $30,329

Provenance

Return type
form_990
Tax year
2023
Filed
21 June 2024
IRS schema version
2023v5.1
Source object
202411739349300746

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.